From: Efficacy and safety of tacrolimus in older adults with ulcerative colitis: a retrospective study
Younger (< 65 yrs. old) n = 110 | Elderly (≥65 yrs. old) n = 19 | p-value | |
---|---|---|---|
TAC administration period (day) | 254.4 ± 251.1 | 156.6 ± 146.6 | 0.0489 |
GFR before TAC administration | 90.7 ± 22.3 | 64.7 ± 14.7 | < 0.0001 |
GFR after TAC administration | |||
After 2 weeks | 86.7 ± 28.4 | 65.5 ± 16.9 | 0.0002 |
Percent change in eGFR after 2 weeks of TAC administration | −3.6 ± 22.2 | 3.1 ± 23.7 | 0.2107 |
After 4 weeks | 85.4 ± 24.1 | 65.9 ± 18.6 | 0.0005 |
Percent change in eGFR after 4 weeks of TAC administration | −6.2 ± 24 | 2.3 ± 19.4 | 0.0971 |
After 12 weeks | 82.9 ± 24.3 | 61.3 ± 16.4 | < 0.0001 |
Percent change in eGFR after 12 weeks of TAC administration | −10 ± 26.4 | −3.2 ± 23.9 | 0.4459 |
After 24 weeks | 78.2 ± 21.5 | 59.6 ± 15.8 | 0.0001 |
Percent change in eGFR after 24 weeks of TAC administration | −15.8 ± 25.4 | −10 ± 28.6 | 0.1851 |
eGFR after 48 weeks of discontinuation | 83.8 ± 18.5 | 62.8 ± 12.9 | < 0.0001 |
Percent change after 48 weeks of discontinuation | −5 ± 18.1 | −0.9 ± 18.1 | 0.2752 |